CLASS III ONGOING Device recall · Reported 12 Aug 2026 · FDA Enforcement Report

Syva Emit Disopyramide Assay Enzyme Immunoassay recalled

Siemens Healthcare Diagnostics is recalling Syva Emit Disopyramide Assay Enzyme Immunoassay, Lidocaine SMN 10445370, distributed nationwide in the US. The recall was initiated on 26 Jun 2026 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesUDI-DI 00842768001406 Lot U1
Quantity recalled8 US; 44 OUS

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2880-2026
FDA event ID
99379
Recalling firm
Siemens Healthcare Diagnostics, Newark, DE
Classification
Class III
Status
Ongoing
Recall initiated
26 Jun 2026
FDA classified
4 Aug 2026
Reported
12 Aug 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

26 Jun 2026Recall initiated by company
4 Aug 2026Classified by FDA+39 days
12 Aug 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome being mild skin or eye irritation and no serious harm anticipated.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Syva Emit Disopyramide Assay Enzyme Immunoassay, Lidocaine SMN 10445370 Catalog No 6N319UL

Where it was distributed

Worldwide - US Nationwide distribution in the states of CA and VA. The country of Japan.

Nationwide CaliforniaVirginia

Questions about this recall

Why was it recalled?

Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome being mild skin or eye irritation and no serious harm anticipated.

Which lots are affected?

UDI-DI 00842768001406 Lot U1

Where was it sold?

Worldwide - US Nationwide distribution in the states of CA and VA. The country of Japan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656